Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuwen Zhu

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
CD137 as a biomarker for tumor-reactive T cells: finding gold in the desertYuwen Zhu, Lieping Chen
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Cancer therapeutic monoclonal antibodies targeting lymphocyte co-stimulatory pathwaysYuwen Zhu, Lieping Chen
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Turning the tide of lymphocyte costimulationYuwen Zhu, Lieping Chen
Nature Reviews. Drug Discovery|February 2, 2013
Advances in targeting cell surface signalling molecules for immune modulationSheng Yao, Yuwen Zhu, Lieping Chen
Immunity|April 23, 2011
Cell surface signaling molecules in the control of immune responses: a tide modelYuwen Zhu, Sheng Yao, Lieping Chen
Annals of Translational Medicine|December 24, 2015
Plasma miRNA, an emerging biomarker for pancreatic cancerXiazhen Yu, Michelle R Koenig, Yuwen Zhu
Molecular Carcinogenesis|March 14, 2020
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapyRobert J Torphy, Richard D Schulick, Yuwen Zhu
Structure (London, England : 1993)|January 13, 2024
Structural insight into CD93 recognition by IGFBP7Yueming Xu, Yi Sun, Yuwen Zhu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Structural insight into CD93 recognition by IGFBP7Yueming Xu, Yi Sun, Yuwen Zhu, et al.
Annals of Gastroenterological Surgery|July 14, 2018
Immunotherapy for pancreatic cancer: Barriers and breakthroughsRobert J Torphy, Yuwen Zhu, Richard D Schulick
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
CD137 as a biomarker for tumor-reactive T cells: finding gold in the desertYuwen Zhu, Lieping Chen
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Cancer therapeutic monoclonal antibodies targeting lymphocyte co-stimulatory pathwaysYuwen Zhu, Lieping Chen
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Turning the tide of lymphocyte costimulationYuwen Zhu, Lieping Chen
Nature Reviews. Drug Discovery|February 2, 2013
Advances in targeting cell surface signalling molecules for immune modulationSheng Yao, Yuwen Zhu, Lieping Chen
Immunity|April 23, 2011
Cell surface signaling molecules in the control of immune responses: a tide modelYuwen Zhu, Sheng Yao, Lieping Chen
Annals of Translational Medicine|December 24, 2015
Plasma miRNA, an emerging biomarker for pancreatic cancerXiazhen Yu, Michelle R Koenig, Yuwen Zhu
Molecular Carcinogenesis|March 14, 2020
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapyRobert J Torphy, Richard D Schulick, Yuwen Zhu
Structure (London, England : 1993)|January 13, 2024
Structural insight into CD93 recognition by IGFBP7Yueming Xu, Yi Sun, Yuwen Zhu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Structural insight into CD93 recognition by IGFBP7Yueming Xu, Yi Sun, Yuwen Zhu, et al.
Annals of Gastroenterological Surgery|July 14, 2018
Immunotherapy for pancreatic cancer: Barriers and breakthroughsRobert J Torphy, Yuwen Zhu, Richard D Schulick
Pageof 12